Pandora A/S PNDORA.CO
Composite 60/100; the shares have moved about 42% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Balance-sheet strength ranks 23/100 — a strong mark against it.
Quality ranks 81/100 — a strong point in its favour. Momentum ranks 76/100 — a strong point in its favour. Valuation ranks 68/100 — a moderate point in its favour.
Balance-sheet strength ranks 23/100 — a strong mark against it. Growth ranks 49/100 — a slight mark against it.
What the company does Pandora A/S designs, crafts, and markets jewelry globally, including charms, carriers, and lab-grown diamonds. It distributes products through physical stores, online platforms, and wholesale channels. Founded in 1982, the company is headquartered in Copenhagen, Denmark.
Key financials Pandora reports strong profitability metrics: ROE 129%, ROA 17%, and ROCE 40%. Gross margins stand at 79%, with operating and net margins at 21% and 16%, respectively. However, revenue and EPS growth are negative at -3% and -10%, respectively.
Stock health The stock shows mixed signals: a high Sideravia Overall score (59) driven by strong Quality (80) and Income (78) pillars, but weak Growth (24). Momentum is positive over 3m (66%) and 6m (66%), yet negative over 12m (-19%). The RSI(14) is 68, indicating near-overbought conditions.
Price vs fair value The stock trades at a **PREMIUM** of 11.14% versus the analyst 12-month target (717.44) and a **discount** of 1.30% versus our fair-value estimate (817.83). - High profitability scores (Quality 80, ROE 129%) support valuation (P/E 12.04). - Weak growth (Revenue -3%, EPS -10%) and elevated multiples (P/B 14.52) may explain the premium to the analyst target. - Strong income yield (2.8%) and FCF yield (6.8%) contribute to valuation support.
Looking forward Forward P/E of 13.07 suggests moderate expectations. Analysts’ premium likely reflects confidence in margin resilience despite revenue declines. Growth recovery remains a key watchpoint.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.